Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| iSpecimen Inc.ISPC · Entity 8372 | Director | December 31, 2022 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
iSpecimen Inc.
Report date December 31, 2022 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,125 |
Reported balance
After 2022-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-10-01 · Grant · Acquired 625 · Balance 3,125 F1: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person. F2: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 841,981 |
Reported balance
Holding disclosure · report date 2022-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 841,981 F3: The indirect ownership consists of 841,981 shares of common stock owned by OBF Investments, LLC. Mr. Scholl is the President and Chief Executive Officer of OBF Investments, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person.
F2: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company.
F3: The indirect ownership consists of 841,981 shares of common stock owned by OBF Investments, LLC. Mr. Scholl is the President and Chief Executive Officer of OBF Investments, LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2023 Filed Jan 13, 2023 17:59 UTC | iSpecimen Inc. ISPC · Entity 8372 | GrantOption · Derivative | 10,000 | $1.41 Strike: $1.41 | $14,100.00 |
DisclosureSEC source: 0001104659-23-003744 · tm233286-2_4seq1.xml · derivative · entry 1 Scholl George H. · CIK 0001857026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,525 Underlying: Common Stock · 10,000 shares Expires 2033-01-03 F1 · derivative.exercise_date: Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| October 01, 2022 Filed Feb 11, 2023 00:44 UTC | iSpecimen Inc. ISPC · Entity 8372 | GrantCommon Stock | 625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-018757 · tm236233-4_5seq1.xml · nonDerivative · entry 1 Scholl George H. · CIK 0001857026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person. F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person. F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company. Read SEC document |
| July 30, 2021 Filed Feb 14, 2022 20:32 UTC | iSpecimen Inc. ISPC · Entity 8372 | GrantNon-Qualified Stock Options · Derivative | 13,525 | Not disclosed Strike: $8.00 | Not disclosed |
DisclosureSEC source: 0001104659-22-022576 · tm226491-8_5seq1.xml · derivative · entry 2 Scholl George H. · CIK 0001857026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,525 Underlying: Common Stock · 13,525 shares Expires not disclosed F3 · security: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement. F4 · price: The NSOs were awarded as compensation to the Reporting Person for his service as a director of the Company. F3 · derivative.exercise_date: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement. F3 · derivative.expiration_date: Each non-qualified stock option ("NSO") represents a contingent right to exercise for one share of common stock upon vesting subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one- year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement. Read SEC document |
| July 30, 2021 Filed Feb 14, 2022 20:32 UTC | iSpecimen Inc. ISPC · Entity 8372 | GrantCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-022576 · tm226491-8_5seq1.xml · nonDerivative · entry 1 Scholl George H. · CIK 0001857026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · security: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock. F1 · shares: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock. F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as the director of the Company. F1 · balance_after: Each share of common stock was awarded as a restricted stock unit ("RSU"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement. 625 RSUs and 625 RSUs were settled for shares of common stock on September 30, 2021 and December 31, 2021, respectively, and the Reporting Person was issued 1,250 shares of common stock. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionBridge Note · Derivative | 119,035 | Not disclosed Strike: $5.60 | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 8 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 119,035 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO. F7 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | OtherBridge Note · Derivative | 364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 7 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,035 Underlying: Common Stock · 364 shares Expires 2021-06-30 F7 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO. F9 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note F7 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO. F7 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 119,035 shares of common stock at $5.60 upon the closing of the IPO. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionConvertible Note · Derivative | 472,490 | Not disclosed Strike: $5.60 | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 6 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 472,490 shares Expires 2021-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO. F6 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | OtherConvertible Note · Derivative | 307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 5 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,490 Underlying: Common Stock · 307 shares Expires 2021-06-30 F6 · derivative.exercise_price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO. F8 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note. F6 · price: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO. F6 · derivative.exercise_date: The convertible note has a maturity date of June 30, 2021 and automatically converted into 472,490 shares of common stock at $5.60 upon the closing of the IPO. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionSeries B Preferred Stock · Derivative | 250,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · derivative · entry 4 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date. F5 · price: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date. F5 · derivative.exercise_date: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date. F5 · derivative.expiration_date: Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionCommon Stock | 119,035 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · nonDerivative · entry 3 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 841,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $666,603 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person. F3 · price: Shares were issued to the reporting person upon conversion of an aggregate of $666,603 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person. F4 · ownership.direct: Mr. George "Bud" Scholl is the President and Chief Executive Officer of OBF Investments, and therefore, may be deemed to hold voting and dispositive power of the securities held by OBF Investments. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionCommon Stock | 472,490 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · nonDerivative · entry 2 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $2,645,945 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person. F2 · price: Shares were issued to the reporting person upon conversion of an aggregate of $2,645,945 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person. F4 · ownership.direct: Mr. George "Bud" Scholl is the President and Chief Executive Officer of OBF Investments, and therefore, may be deemed to hold voting and dispositive power of the securities held by OBF Investments. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:58 UTC | iSpecimen Inc. ISPC · Entity 8372 | ConversionCommon Stock | 250,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084748 · tm2120463-4_4seq1.xml · nonDerivative · entry 1 OBF Investments, LLC · CIK 0001857012 · 10% owner Scholl George H. · CIK 0001857026 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion. F1 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion. F4 · ownership.direct: Mr. George "Bud" Scholl is the President and Chief Executive Officer of OBF Investments, and therefore, may be deemed to hold voting and dispositive power of the securities held by OBF Investments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.